On February 9, 2018 pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug products and technologies, reported that Nancy Lurker, President and Chief Executive Officer, is scheduled to present an overview of the Company and its progress at the Annual BIO CEO & Investor Conference on Tuesday, February 13, 2018, at 2:30 p.m. ET (Press release, pSivida, FEB 9, 2018, View Source [SID1234523874]). The conference will be held in New York, NY.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio and/or webcast and subsequent archived replay of pSivida’s presentation may be accessed via the Investors section of the Company’s website under "Resources – Events & Presentations" at www.psivida.com. The replay will be available for 90 days after the event.